Eli Lilly and Company (LLY) vs Lam Research Corporation (LRCX)

See how Eli Lilly and Company and Lam Research Corporation differ across market data and performance, so you can decide which asset best fits your strategy.

$1,156.73
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page
$301.49
NasdaqGS
Lam Research Corp is one of the world’s leading manufacturers of semiconductor wafer fabrication equipment. The company specializes in deposition and etch technologies, which involve building layers on a semiconductor wafer and selectively removing patterns from each layer. Lam holds the leading market share in etch and ranks a clear second in deposition. It has greater exposure to memory chipmakers, particularly in DRAM and NAND. Its major customers include some of the world’s largest semiconductor companies, such as TSMC, Samsung, Intel, and Micron.
View Full Page

Key Metrics Comparison

Eli Lilly and CompanyLLY
Market Cap
$1.032T
Price
$1,156.73
24h Change
-1.52%
24h Volume
$3.03M
Employees
50,000
Shares Outstanding
944,818,881
Lam Research CorporationLRCX
Market Cap
$377.261B
Price
$301.49
24h Change
-0.14%
24h Volume
$6.95M
Employees
20,600
Shares Outstanding
1,250,571,000

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
LLY
73.2%
LRCX
26.8%

Volume Share

Share of combined 24h volume

Volume Share
LLY
30.4%
LRCX
69.6%

24h Performance

Price change over last 24 hours

24h Performance
LLY
-1.52%
LRCX
-0.14%
Price Comparison
Eli Lilly and Company
Lam Research Corporation